VISTA PHARMACEUTICALS LTD.
BSE: 524711
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 0.00-100.0% | 2.42+65.3% | 1.46-3.7% | 1.52-53.0% | 3.23+26.4% | 2.56+2.4% | 2.50 |
| Other Income | 0.03-63.5% | 0.09-53.3% | 0.19 | 0.00-100.0% | 0.24+97.2% | 0.12+1642.9% | 0.01 |
| Total Income | 0.03-98.7% | 2.51+51.5% | 1.65+9.0% | 1.52-56.2% | 3.47+29.6% | 2.68+7.0% | 2.50 |
| EXPENSES | |||||||
| Expenditure | 7.80+34.8% | 5.79+9.7% | 5.28+76.0% | 3.00-33.8% | 4.53+1.2% | 4.48+19.4% | 3.75 |
| Tax | -1.91-98.3% | -0.96+7.0% | -1.03-444.8% | -0.19-143.8% | 0.43-10.0% | 0.48+73.4% | 0.28 |
| PROFIT | |||||||
| PBT | -7.77-136.8% | -3.28+9.4% | -3.62-144.7% | -1.48-39.4% | -1.06+41.1% | -1.80-44.1% | -1.25 |
| Net Profit | -5.86-152.8% | -2.32+10.4% | -2.59-100.6% | -1.29+13.7% | -1.50-13.1% | -1.32-35.7% | -0.97 |
| KEY METRICS | |||||||
| OPM % | — | -100.00% | -100.00%-26.83pp | -73.17%-44.94pp | -28.23%+63.20pp | -91.43%-23.49pp | -67.94% |
| NPM % | -100.00%-7.52pp | -92.48%+7.52pp | -100.00%-15.03pp | -84.97%-41.88pp | -43.09%+6.29pp | -49.38%-10.45pp | -38.93% |
| EPS | 0.91+122.0% | 0.41-2.4% | 0.42+90.9% | 0.22-15.4% | 0.26+471.4% | -0.07 | — |
Corporate Events
Board MeetingVISTAPH
202629May
Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗ Board MeetingVISTAPH
202613Feb
Board Meeting
Unaudited financial results for the quarter and nine months …
BSE Filing ↗ Board MeetingVISTAPH
202413Nov
Board Meeting
Un Audited financial results for the quarter ended 30.09.202…
BSE Filing ↗ Board MeetingVISTAPH
202428May
Board Meeting
Consideration and approval of audited financial results for …
BSE Filing ↗